Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 15, 2025
September 15, 2025
New ‘Home and Soul Harmony’ Show Featuring a Fitness Guru and a Master Interior Designer is Designed to Feed the Soul
Indeterminate
EIN Presswire
September 15, 2025
Evok Healthcare Marketing Shares Strategies for High-Value Healthcare Service Line Marketing and Revenue Growth
Indeterminate
EIN Presswire
September 15, 2025
Nearly 80,000 Doctors Have Left Private Practice: New Marketing Agency Aims to Reverse the Trend
Indeterminate
EIN Presswire
September 15, 2025
Jean Fallacara Joins Jupiter Neurosciences as Co-Chairman of the Scientific Advisory Board for Nugevia™
Indeterminate
EIN Presswire
September 15, 2025
Diverse Biotech Inc. Initiates Regulation D Private Placement to Fund Accelerated Development of new Antibiotic Class
Indeterminate
EIN Presswire
September 15, 2025
VitalHub Announces Change of Auditor
Indeterminate
GlobeNewswire
September 15, 2025
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Indeterminate
GlobeNewswire
September 15, 2025
Supporting Heart Health in Our Communities
Indeterminate
GlobeNewswire
September 15, 2025
Graphy Demonstrates Expansion of Digital Dental Solutions at WDSS 2025
Indeterminate
EIN Presswire
September 15, 2025
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
Indeterminate
GlobeNewswire
September 15, 2025
Dr. Barbara Knox Drives Pediatric Efforts to Improve Child Protection Nationwide
Indeterminate
EIN Presswire
September 15, 2025
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Indeterminate
GlobeNewswire
September 15, 2025
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.
Indeterminate
GlobeNewswire
September 15, 2025
Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
Indeterminate
GlobeNewswire
September 15, 2025
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
Indeterminate
GlobeNewswire